Altera Biosciences is a preclinical-stage biotechnology company developing a universal donor cell platform to power the next generation of off-the-shelf allogeneic cell therapies. Our mission is to remove the barriers of immunogenicity and donor-matching through cell engineering — making cell therapy more scalable, accessible, and impactful across the globe.
Company Details
- Employees
- 3
- Address
- One Of The Biggest Challenges In Transplantation And Advanced Therapies: The Limited Availability Of Immunologically Compatible Donors.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.altera-bio.com
- Keywords
- Cape Town.
Altera Biosciences Questions
Altera Biosciences's website is http://www.altera-bio.com
Altera Biosciences's LinkedIn profile is https://www.linkedin.com/company/altera-biosciences-inc
Altera Biosciences has
3 employees.
View email and phone details for 3
employees at Altera Biosciences.
Altera Biosciences's industry is
Biotechnology Research
Altera Biosciences's top competitors are
Gate Bioscience,
Novita Biotechnology,
Lusandi Medical Animations Studio,
Onebio Venture Studio,
Yolo Immune Inc,
Roche,
Africaworks South Africa,
Startup Club Za,
E Squared Investments,
Precium.
Altera Biosciences's categories are Biotechnology Research
